227 related articles for article (PubMed ID: 31503425)
21. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
[TBL] [Abstract][Full Text] [Related]
22. TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma.
Mullen DJ; Yan C; Kang DS; Zhou B; Borok Z; Marconett CN; Farnham PJ; Offringa IA; Rhie SK
PLoS Genet; 2020 Sep; 16(9):e1009023. PubMed ID: 32925947
[TBL] [Abstract][Full Text] [Related]
23. A global view of regulatory networks in lung cancer: An approach to understand homogeneity and heterogeneity.
Lu J; Wang W; Xu M; Li Y; Chen C; Wang X
Semin Cancer Biol; 2017 Feb; 42():31-38. PubMed ID: 27894849
[TBL] [Abstract][Full Text] [Related]
24. Dynamical network analysis reveals key microRNAs in progressive stages of lung cancer.
Kong C; Yao YX; Bing ZT; Guo BH; Huang L; Huang ZG; Lai YC
PLoS Comput Biol; 2020 May; 16(5):e1007793. PubMed ID: 32428028
[TBL] [Abstract][Full Text] [Related]
25. Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.
Yang X; Huang WT; Wu HY; He RQ; Ma J; Liu AG; Chen G
Oncol Rep; 2019 Apr; 41(4):2241-2253. PubMed ID: 30816547
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma.
Xiao J; Liu A; Lu X; Chen X; Li W; He S; He B; Chen Q
Sci Rep; 2017 May; 7(1):2027. PubMed ID: 28515486
[TBL] [Abstract][Full Text] [Related]
27. Search for Master Regulators in Walking Cancer Pathways.
Kel AE
Methods Mol Biol; 2017; 1613():161-191. PubMed ID: 28849562
[TBL] [Abstract][Full Text] [Related]
28. Identification of Biomarker and Co-Regulatory Motifs in Lung Adenocarcinoma Based on Differential Interactions.
Zhao N; Liu Y; Chang Z; Li K; Zhang R; Zhou Y; Qiu F; Han X; Xu Y
PLoS One; 2015; 10(9):e0139165. PubMed ID: 26402252
[TBL] [Abstract][Full Text] [Related]
29. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
30. EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma.
Shao B; Bjaanæs MM; Helland Å; Schütte C; Conrad T
PLoS One; 2019; 14(1):e0204186. PubMed ID: 30703089
[TBL] [Abstract][Full Text] [Related]
31. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
Ho KH; Chang CJ; Huang TW; Shih CM; Liu AJ; Chen PH; Cheng KT; Chen KC
PLoS One; 2018; 13(12):e0208459. PubMed ID: 30521597
[TBL] [Abstract][Full Text] [Related]
32. Identification of key transcription factors in endometrial cancer by systems bioinformatics analysis.
Song Y; Chen QT; He QQ
J Cell Biochem; 2019 Sep; 120(9):15443-15454. PubMed ID: 31037767
[TBL] [Abstract][Full Text] [Related]
33. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation.
Liu L; Ni J; He X
Dis Markers; 2018; 2018():5736716. PubMed ID: 30154938
[TBL] [Abstract][Full Text] [Related]
35. Proliferation genes in lung development associated with the prognosis of lung adenocarcinoma but not squamous cell carcinoma.
Li P; Zhang L; Yu X; Tong R; Di X; Mao Y; Gao Y; Zhang K; Feng L; Cheng S
Cancer Sci; 2018 Feb; 109(2):308-316. PubMed ID: 29168602
[TBL] [Abstract][Full Text] [Related]
36. Gene identification for risk of relapse in stage I lung adenocarcinoma patients: a combined methodology of gene expression profiling and computational gene network analysis.
Ludovini V; Bianconi F; Siggillino A; Piobbico D; Vannucci J; Metro G; Chiari R; Bellezza G; Puma F; Della Fazia MA; Servillo G; Crinò L
Oncotarget; 2016 May; 7(21):30561-74. PubMed ID: 27081700
[TBL] [Abstract][Full Text] [Related]
37. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
Rajamani D; Bhasin MK
Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215
[TBL] [Abstract][Full Text] [Related]
38. A co-expressed gene status of adenylate kinase 1/4 reveals prognostic gene signature associated with prognosis and sensitivity to EGFR targeted therapy in lung adenocarcinoma.
Jan YH; Lai TC; Yang CJ; Huang MS; Hsiao M
Sci Rep; 2019 Aug; 9(1):12329. PubMed ID: 31444368
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma.
Zhang L; Zhang Z; Yu Z
J Transl Med; 2019 Dec; 17(1):423. PubMed ID: 31847905
[TBL] [Abstract][Full Text] [Related]
40. A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma.
Liao M; Liu Q; Li B; Liao W; Xie W; Zhang Y
Cancer Sci; 2018 Dec; 109(12):4033-4044. PubMed ID: 30290038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
